Medtronic Secures Exclusive U.S. Distribution and Option to Acquire Contego Medical, Developer of the Neuroguard® 3-in-1 Carotid Stent System

Jan 13, 2025 22:15 CST Updated 22:15

Medtronic

Medical Device Manufacturer

Contego Medical

Developer of Thrombosis Protection Devices

Medtronic announced withContego MedicalSigned an exclusive distribution agreement in the United States,Contego MedicalCore ProductsNeuroguardIt was approved by the FDA in October last year for market release, used to streamline surgical steps during carotid artery revascularization and capable of capturing emboli during the procedure, thereby protecting patients from stroke.

Executive Evaluation

"Contego's innovation, supported by outstanding data, is transforming the treatment of carotid artery disease and complementing Medtronic's peripheral and stroke protection portfolio. This strategic agreement with Contego Medical expands our commitment to this rapidly growing carotid market and reflects Medtronic's unwavering dedication to advancing innovation and enhancing patient care."

---David Moeller, Senior Vice President and President of Peripheral Vascular Health at Medtronic

"This strategic agreement marks an important milestone for Contego Medical and Medtronic. By combining our innovative product portfolio with Medtronic's extensive market presence and clinical leadership, we are poised to revolutionize revascularization treatments in the fields of carotid and peripheral vascular disease. This partnership enhances our ability to deliver cutting-edge solutions to patients and reinforces our commitment to expanding treatment options across the United States."

---Ravish Sachar, Founder and CEO of Contego Medical

In addition to signingIn addition to the exclusive distribution agreement, Medtronic alsoContego MedicalMake investments and achieve acquisitionsContego MedicalOption. Medtronic &Contego MedicalThe origin can be traced back to 2020, when Medtronic invested.Contego Medical, ownsContego MedicalMinority interest.

Contego MedicalProductsNeuroguardEffectively complement Medtronic's peripheral product line. Last year, Boston Scientific acquired it for $1.2 billion.Silk Road Medical。Silk Road Medical"Transcarotid Artery Revascularization (TCAR)" Technology andContego MedicalTheNeuroguardBoth are used for carotid artery revascularization. FutureNeuroguardTCAR and Medtronic and Boston Scientific will fiercely compete in the carotid revascularization market.

According toContego MedicalThe published data shows:NeuroguardSuperior to TCAR

NeuroguardClinical studies (PERFORMANCE I and PERFORMANCE II IDE) both demonstrated high safety: within 30 days and 1 year.No major stroke, no neurological death, and no stent thrombosis. Biboke has just acquired Silk Road's TCAR technology, which has a lower risk of embolic stroke.

Contego MedicalIn order to make its products more competitive, it is also developing the next generation.Neuroguard。If the next generationNeuroguardThe superior outcomes will significantly alter the landscape of the carotid artery revascularization market and also increase the likelihood of Medtronic's acquisition.Contego MedicalProbability.

Neuroguard

NeuroguardUsing Contego Medical's unique Integrated Embolic Protection (IEP) technology, its standout feature is the integration of a 40μm micropore filter on a 6Fr balloon catheter.Embolic ProtectionFilter, Carotid Artery Stent,Embolic ProtectionThe filter and balloon catheter are integrated into one unit.

Embolization ProtectionThe filter isNeuroguardThe core technology features a filter with micropores of only 40μm, which is 1/4 to 1/3 the size of traditional filters. Moreover, doctors can adjust the filter size according to the patient's anatomical and physiological structure.Thereby improving strokeAnd the protection of cognitive impairment.

In additionNeuroguardTwo types of stents can be provided—closed-cell stents or open-cell stents. Closed-cell stents exhibit a high degree of adaptability, showing significant short-term and long-term durability, with no thrombosis, no clinically-driven target lesion revascularization, and a very low restenosis rate within one year.

Neuroguard Demonstration

Contego Medical

Contego MedicalContego Medical is an innovative medical device company that provides a variety of peripheral blood solutions, converting complex cases into simplified procedures. Its integrated multifunctional product portfolio aims to improve patient outcomes and procedural efficiency in the treatment of carotid and peripheral vascular diseases.